GLAXOSMITHKLINE LLC (formerly known as SmithKline Beecham Corporation), Plaintiff-Appellee,
v.
BANNER PHARMACAPS, INC. and Impax Laboratories, Inc., Defendants-Appellants, and
Roxane Laboratories, Inc., Defendant-Appellant, and
Mylan Inc. and Mylan Pharmaceuticals Inc., Defendants-Appellants, and
Watson Laboratories, Inc. Florida, Defendant-Appellant.
United States Court of Appeals, Federal Circuit.https://leagle.com/images/logo.png
Before O'MALLEY, WALLACH, and TARANTO, Circuit Judges.
United States Court of Appeals, Federal Circuit.
TARANTO, Circuit Judge.
Plaintiff GlaxoSmithKline LLC ("GSK") sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. — Florida (collectively, "Defendants"). Invoking 35 U.S.C. § 271(e)(2), GSK alleged that drug products containing the molecule dutasteride that Defendants propose to market fall within claims of U.S. Patent No. 5,565,467, which covers dutasteride...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.